Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Digestive Diseases and Sciences

• Publication date

  2016-03-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-016-4124-3PMID 26993824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of developing advanced colorectal neoplasia after removing high‐risk adenoma detected at index colonoscopy in young patients: A KASID study

  2016cited by this paper
• Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

  2015cited by this paper
• Interferon-free combination therapies for the treatment of hepatitis C: current insights

  2015cited by this paper
• Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

  2015cited by this paper
• Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.

  2015cited by this paper
• Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

  2015cited by this paper
• The Epidemiology of Cirrhosis in the United States: A Population-based Study

  2015cited by this paper
• Low Awareness of Nonalcoholic Fatty Liver Disease Among Patients at High Metabolic Risk

  2015cited by this paper
• The role of diet and nutritional intervention for the management of patients with NAFLD.

  2014cited by this paper
• Mortality From Chronic Liver Diseases in Diabetes

  2014cited by this paper
• Obesity-associated nonalcoholic fatty liver disease.

  2014cited by this paper
• Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease.

  2014cited by this paper
• Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

  2013cited by this paper
• Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

  2013cited by this paper
• Awareness and opinions of non‐alcoholic fatty liver disease by hospital specialists

  2013cited by this paper
• The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cited by this paper
• Why Does Patient Activation Matter? An Examination of the Relationships Between Patient Activation and Health-Related Outcomes

  2012cited by this paper
• Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11‐year follow‐up study

  2012cited by this paper
• Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis.

  2012cited by this paper
• Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

  2012cited by this paper
• Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

  2011cited by this paper
• Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

  2011cited by this paper
• Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

  2005cited by this paper
• Non‐alcoholic steatohepatitis in type 2 diabetes mellitus

  2004cited by this paper
• How much do diabetic patients know about diabetes mellitus and its complications?

  2004cited by this paper
• Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

  1997cited by this paper
• Intensive nutrition counseling enhances outcomes of National Cholesterol Education Program dietary therapy.

  1996cited by this paper
• in the United States and in

  1981cited by this paper
• Annals of the New York Academy of Sciences Nonalcoholic Fatty Liver Disease: an Emerging Threat to Obese and Diabetic Individuals

  year unknowncited by this paper

• Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• When to refer patients for liver elastography

  2024cites this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective

  2023influential citation
• Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study

  2023cites this paper
• Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats

  2020cites this paper
• Underdiagnosis of non-alcoholic fatty liver, an international phenomenon

  2020cites this paper
• Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best Practice.

  2020cites this paper
• Nonalcoholic Fatty Liver Disease and the Need for Action.

  2020cites this paper
• Clinical Utility of a Risk‐Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

  2019cites this paper
• Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment

  2019cites this paper
• TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor

  2019cites this paper
• The evaluation of complications and mortality in non-alcoholic steatohepatitis related cirrhosis

  2018cites this paper
• Coronary artery disease in decompensated patients undergoing liver transplantation evaluation

  2018cites this paper
• Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma

  2017influential citation
• Helicobacter pylori on portal hypertension-related hepatic encephalopathy

  2017cites this paper
• Evaluation of coronary artery disease in potential liver transplant recipients

  2017cites this paper
• Early Detection of Steatohepatitis: Less Teeth NASHing and More Research?

  2016cites this paper
• Adverse cardiac events after orthotopic liver transplantation: A cross‐sectional study in 389 consecutive patients

  2015cites this paper
• Evaluation of Solid Organ Transplant Candidates for Coronary Artery Disease

  2014cites this paper